X4 Pharmaceuticals
XFOR
XFOR
89 hedge funds and large institutions have $73.2M invested in X4 Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 97 → 89 (-8)
29% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 21
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
89
Holding in Top 10
–
Calls
$550K
Puts
$134K
Top Buyers
| 1 | +$1.26M | |
| 2 | +$562K | |
| 3 | +$493K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$486K |
| 5 |
JPMorgan Chase & Co
New York
|
+$281K |
Top Sellers
| 1 | -$2.86M | |
| 2 | -$2.37M | |
| 3 | -$872K | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$548K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$505K |